Oral olanzapine a guide to its use in adults with

Authors: Katherine A LysengWilliamson

Publish Date: 2013/09/03

Volume: 29, Issue: 10, Pages: 291-296

PDF Link

Abstract

Olanzapine an atypical antipsychotic is a wellestablished option for the firstline treatment of schizophrenia and as firstline or adjunctive therapy in the acute or preventative treatment of manic or mixed episodes associated with bipolar I disorder The use of olanzapine is associated with better or similar efficacy than other commonly used antipsychotics which may result in lower rates of treatment discontinuation Treatment may generally be initiated at therapeutic dosages Relative to other antipsychotics olanzapine has a lower risk of extrapyramidal symptoms but a greater risk of weight gainThe preparation of this article was not supported by any external funding During the review process the manufacturer of the agent under review will be offered an opportunity to comment on the articles Changes resulting from comments received will be made by the author on the basis of scientific and editorial merit

Keywords: